A Pilot, Randomized, Double-Blind, Placebo-Controlled Phase I Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Types 1,2,3,and 6

Research output: Other contributionOther

Original languageAmerican English
StatePublished - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Disciplines

  • Epidemiology
  • Public Health

Cite this